Concert Pharmaceuticals to Present at Upcoming Investor Conferences
01 Septiembre 2016 - 6:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will present a corporate overview at the following upcoming
investor conferences:
- The Wells Fargo Securities 2016
Healthcare Conference on September 8, 2016 at 2:20 p.m. EDT in
Boston, MA; and
- The Ladenburg Thalmann 2016 Healthcare
Conference on September 27, 2016 at 9:30 a.m. EDT in New York,
NY.
A live webcast of Concert’s presentations at these conferences
may be accessed in the Investors section of the Company’s website
at www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the webcast will be available on Concert’s website for 2
weeks following each presentation.
Concert Pharmaceuticals is a clinical stage biopharmaceutical
company focused on applying its DCE Platform® (deuterated chemical
entity platform) to create novel medicines designed to address
unmet patient needs. The Company’s approach starts with approved
drugs in which deuterium substitution has the potential to enhance
clinical safety, tolerability or efficacy. Concert has a broad
pipeline of innovative medicines targeting pulmonary diseases,
including cystic fibrosis, central nervous systems (CNS) disorders,
as well as autoimmune and inflammatory diseases. For more
information please visit www.concertpharma.com.
Concert Pharmaceuticals Inc., the CoNCERT
Pharmaceuticals Inc. logo and DCE Platform are registered
trademarks of Concert Pharmaceuticals, Inc.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160901005054/en/
Concert Pharmaceuticals, Inc.Justine E. Koenigsberg,
781-674-5284Vice President, Corporate Communications and Investor
Relationsir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Concert Pharmaceuticals, Inc. (MM) Artículos de Noticias